Google Übersetzer
Compass Therapeutics Inc.
About
Compass Therapeutics Inc. (NASDAQ:CMPX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 24 2026
Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer
Mar 5 2026
Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update
Jan 6 2026
Compass Therapeutics Provides Corporate Update
Jan 5 2026
Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 5 2026
Compass Therapeutics Announces Key Leadership Appointments
Financials
Revenue
$0
Market Cap
$981.48 M
EPS
-0.42